• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Oncology  • Oncology, Other  • Quality of Care  • Patient Safety/ Medical Error  • Statistics and Research Methods  • Surgery  • Surgical Interventions  • Endoscopy/ Minimally Invasive Surgery  • Surgical Oncology  • Prognosis/ Outcomes  • Hepatobiliary Surgery  • Gastroenterology  • Liver/ Biliary Tract/ Pancreatic Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

A Single-Center UK Experience

Mohammed Abu Hilal, MD, PhD, FRCS; Francesco Di Fabio, MD; Mahdi Abu Salameh, MD; Neil William Pearce, DM, FRCS

Arch Surg. 2012;147(1):42-48. doi:10.1001/archsurg.2011.856

Objective  To assess the oncological efficiency of laparoscopic minor and major hepatectomy for primary and metastatic liver malignant neoplasms.

Design  Retrospective single-center study.

Setting  Tertiary university hospital.

Patients  One hundred twenty-eight patients undergoing 133 laparoscopic liver resections for malignant diseases.

Main Outcome Measures  Perioperative results and midterm overall and disease-free survival.

Results  Surgical indications were colorectal carcinoma liver metastasis (n = 83), hepatocellular carcinoma (n = 18), neuroendocrine tumor metastasis (n = 17), non–colorectal carcinoma liver metastasis (n = 11), lymphoma (n = 2), and intrahepatic cholangiocarcinoma (n = 2). Two patients had 2-stage laparoscopic resections for bilobar colorectal carcinoma liver metastasis. Three patients had repeated liver resection for recurrent colorectal carcinoma liver metastasis. Forty-two major hepatectomies (32%) were performed. The median operative time was 210 minutes (range, 30-480 minutes). The median postoperative length of stay was 4 days (range, 1-15 days). Seven patients required conversion to formal open surgery and 4 patients required conversion to a laparoscopic-assisted procedure. Sixteen patients (13%) developed significant postoperative complications. One patient (0.8%) died in the hospital. In the 17 patients with neuroendocrine tumor metastasis, 6 (35%) had microscopic positive resection margins. Most of these patients underwent debulking and cytoreductive surgery. A microscopic negative resection margin was obtained in the remaining 112 of 116 resections (97%). We recorded 2-year overall survivals of 80%, 77%, and 91% in the groups with colorectal carcinoma liver metastasis, hepatocellular carcinoma, and neuroendocrine tumor metastasis, respectively.

Conclusions  Our data support the safety and oncological efficiency of laparoscopic resection for liver malignant neoplasms. Adequate patient selection and extensive experience in hepatic and laparoscopic surgery are essential prerequisites to optimize outcomes.

Author Affiliations: Hepatobiliary and Pancreatic Surgical Unit (Drs Abu Hilal, Di Fabio, and Pearce) and Department of Gastroenterology (Dr Abu Salameh), University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Laparoscopic vs Open Liver Resection: Comment on "Oncological Efficiency Analysis of Laparoscopic Liver Resection for Primary and Metastatic Cancer"
Jake Krige and Delawir Kahn
Arch Surg. 2012;147(1):48.
EXTRACT | FULL TEXT